fluorodeoxyglucose f18 has been researched along with 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dresel, S; Horak, M; Rüther, T; Soyka, M; Tatsch, K | 1 |
| Amthauer, H; Felix, R; Harnack, D; Klaffke, S; Kuhn, AA; Kupsch, A; Plotkin, M | 1 |
| Afzal, W; Apostolova, I; Buchert, R; Buhmann, C; Derlin, T; Hesse, S; Klutmann, S; Meyer, PT; Wilke, F | 1 |
| Hermann, W | 1 |
1 review(s) available for fluorodeoxyglucose f18 and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
| Article | Year |
|---|---|
Morphological and functional imaging in neurological and non-neurological Wilson's patients.
Topics: Benzamides; Brain; Cocaine; Copper; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Positron-Emission Tomography; Pyrrolidines; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2014 |
3 other study(ies) available for fluorodeoxyglucose f18 and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
| Article | Year |
|---|---|
PET and SPECT findings in alcohol hallucinosis: case report and super-brief review of the pathophysiology of this syndrome.
Topics: Alcoholism; Benzamides; Brain; Fluorodeoxyglucose F18; Hallucinations; Humans; Iodine Radioisotopes; Male; Middle Aged; Pyrrolidines; Radiopharmaceuticals; Serotonin; Syndrome; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
Topics: Aged; Benzamides; Blood Glucose; Brain; Cerebral Cortex; Cocaine; Corpus Striatum; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Parkinsonian Disorders; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes | 2006 |
IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement.
Topics: Benzamides; Diagnosis, Differential; Dopamine Antagonists; Fluorodeoxyglucose F18; Humans; Observer Variation; Parkinsonian Disorders; Patient Selection; Positron-Emission Tomography; Pyrrolidines; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2010 |